NCT01361061View on ClinicalTrials.gov

AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Liver Cirrhosis
Trial Locations (2)

55131

University Medical Center Mainz, Mainz

79106

University Medical Center Freiburg, Freiburg im Breisgau

Sponsors

Collaborators (1)

Wako Diagnostics
All Listed Sponsors
collaborator

Wako Diagnostics

INDUSTRY

collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

University Hospital Heidelberg

OTHER

lead

University Hospital Freiburg

OTHER

NCT01361061 - AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver | Biotech Hunter | Biotech Hunter